Clinical Trial Update: Comparison Between Whole Body DWI and FDG PET/CT in Patients with Simptomatic Multiple Myeloma

View source ↗

Summary

A clinical trial evaluating whole body diffusion-weighted MRI (DWI) versus FDG PET/CT in symptomatic multiple myeloma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Multiple Myeloma | Status: RECRUITING